Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VARDI, Y.
Right arrow Articles by ZOR, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VARDI, Y.
Right arrow Articles by ZOR, U.
NEUROLOGY 1976;26:447
© 1976 American Academy of Neurology

Migraine attacks

Alleviation by an inhibitor of prostaglandin synthesis and action

Y. VARDI, M.D., I. M. RABEY, M.D., M. STREIFLER, M.D., A. SCHWARTZ, M.D., H. R. LINDNER, Ph.D. and U. ZOR, Ph.D.

From the Department of Neurology, Municipal Governmental Medical Center, Ichilov Hospital, Tel Aviv University Medical School, the Department of Obstetrics and Gynecology, Zahalon Governmental Hospital, Tel Aviv-Jaffa, and the Department of Hormone Research, the Weizmann Institute of Science, Rehovot, Israel.

Twenty-six patients with migraine attacks were treated for 3 to 16 months with flufenamic acid (125 mg four to six times per attack), an inhibitor of prostaglandin synthesis and action. In 25 patients the drug afforded symptomatic relief in 195 of 200 treated attacks. Side effects observed were mild dyspepsia (eight patients) and severe upper gastrointestinal symptoms (two patients). None of the eight patients treated with placebo reported any relief (20 attacks). The "common" antimigraine drugs afforded symptomatic relief in 12 of the patients, partial relief in seven, and no relief in seven. Treatment with flufenamic acid was based on the hypothesis that prostaglandins are involved in migraine attack and that the drug relieves migraine by inhibition of the vasoactivity of prostaglandins.

Requests for reprints should be addressed to U. Zor, Ph.D., Department of Hormone Research, the Weizmann Institute of Science, Rehovot, Israel.

Received for publication May 27, 1975.




This article has been cited by other articles:


Home page
Arch NeurolHome page
D. K. Ziegler and D. J. Ellis
Naproxen in Prophylaxis of Migraine
Arch Neurol, June 1, 1985; 42(6): 582 - 584.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.